Aeterna Zentaris Inc. (AEZS) SEC Filing 6-K Foreign Issuer report for the period ending Saturday, June 30, 2018

Aeterna Zentaris Inc.

CIK: 1113423 Ticker: AEZS

View differences made from one to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..


Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits

Ticker: AEZS
CIK: 1113423
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001628280-18-010941
Submitted to the SEC: Thu Aug 09 2018 4:11:35 PM EST
Accepted by the SEC: Thu Aug 09 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: